Concepedia

Ismael Zamora

IZ

44

Publications

2.4K

Citations

28

H-Index

1996

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Universitat Pompeu Fabra

Uppsala University

Molecular Discovery (United Kingdom)

Median SCP (Spain)

Ismael Zamora is an author at AstraZeneca (Sweden) specializing in medicine, biochemistry, and drug discovery.

Top concepts

MedicineBiochemistryDrug DiscoveryPharmacologyNatural SciencesMolecular DockingMedicinal ChemistryEngineeringMolecular BiologyBioanalysis

Publications per year

1996–2020

44

Publications

44

pH-Dependent Bidirectional Transport of Weakly Basic Drugs Across Caco-2 Monolayers: Implications for Drug–Drug Interactions

Sibylle Neuhoff, Anna‐Lena Ungell, Ismael Zamora et al. · Pharmaceutical Research · 2003 · 207 citations

pH-Dependent passive and active transport of acidic drugs across Caco-2 cell monolayers

Sibylle Neuhoff, Anna‐Lena Ungell, Ismael Zamora et al. · European Journal of Pharmaceutical Sciences · 2005 · 147 citations

Molecular Pharmacology, Acidic Drugs, Proteinlipid Interaction +13

Contribution of solid-state properties to the aqueous solubility of drugs

Carola M. Wassvik, Anders Holmén, Christel A. S. Bergström et al. · European Journal of Pharmaceutical Sciences · 2006 · 139 citations

Materials Science, Engineering, Aqueous Solubility +8

Predicting Drug Metabolism: A Site of Metabolism Prediction Tool Applied to the Cytochrome P450 2C9

Ismael Zamora, Lovisa Afzelius, Gabriele Cruciani · Journal of Medicinal Chemistry · 2003 · 137 citations

Bioorganic Chemistry, Metabolomic Profiling, Metabolic Model +16

CYP2C9 Structure−Metabolism Relationships: Optimizing the Metabolic Stability of COX-2 Inhibitors

Marie M. Ahlström, Marianne Ridderström, Ismael Zamora et al. · Journal of Medicinal Chemistry · 2007 · 102 citations

Bioorganic Chemistry, Cox-2 Selective Inhibitor, Metabolic Remodeling +16

Rows per page

1–5 of 44